Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Aug;84(2):427–434. doi: 10.1172/JCI114183

Biphasic forearm vascular responses to intraarterial arginine vasopressin.

S Suzuki 1, A Takeshita 1, T Imaizumi 1, Y Hirooka 1, M Yoshida 1, S Ando 1, M Nakamura 1
PMCID: PMC548900  PMID: 2547832

Abstract

Forearm vascular responses to arginine vasopressin (AVP) infused into a brachial artery in a wide range of infusion rates (0.05-2.0 ng/kg per min) were examined in 20 young healthy volunteers. Intraarterial AVP at lower doses (0.05 and 0.1 ng/kg per min) caused forearm vasoconstriction, whereas AVP at a dose of 0.2 ng/kg per min or higher caused forearm vasodilatation. The maximal forearm vasoconstriction was induced at the venous plasma AVP level of 76.3 +/- 8.8 pg/ml. Forearm vasodilatation was associated with the venous plasma AVP level of 369 +/- 43 pg/ml or higher. Forearm vasodilatation was the result of the direct effect of AVP since forearm blood flow and vascular resistance in the contralateral arm did not change. We attempted to explore the mechanisms involved in AVP-induced direct vasodilatation. The treatment with indomethacin, 75 mg/d for 3 d, did not alter AVP-induced forearm vasodilatation. In contrast, intraarterial infusion of isoosmolar CaCl2 totally prevented AVP-induced forearm vasodilatation. Intra-arterial CaCl2 also markedly attenuated forearm vasodilatation induced by intraarterial sodium nitroprusside, but did not alter forearm vasodilatation induced by intraarterial isoproterenol. These results indicate that the direct vascular effects of intra-arterial AVP on the forearm vessels are biphasic, causing vasoconstriction at lower doses and vasodilatation at higher doses. The direct vasodilatation induced by intraarterial AVP at higher doses is not mediated by prostaglandins but may involve cGMP-related mechanisms.

Full text

PDF
427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abboud F. M., Aylward P. E., Floras J. S., Gupta B. N. Sensitization of aortic and cardiac baroreceptors by arginine vasopressin in mammals. J Physiol. 1986 Aug;377:251–265. doi: 10.1113/jphysiol.1986.sp016185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abe K. The kinins and prostaglandins in hypertension. Clin Endocrinol Metab. 1981 Nov;10(3):577–605. doi: 10.1016/s0300-595x(81)80013-8. [DOI] [PubMed] [Google Scholar]
  3. Altura B. M., Altura B. T. Vascular smooth muscle and neurohypophyseal hormones. Fed Proc. 1977 May;36(6):1853–1860. [PubMed] [Google Scholar]
  4. Aylward P. E., Floras J. S., Leimbach W. N., Jr, Abboud F. M. Effects of vasopressin on the circulation and its baroreflex control in healthy men. Circulation. 1986 Jun;73(6):1145–1154. doi: 10.1161/01.cir.73.6.1145. [DOI] [PubMed] [Google Scholar]
  5. BRAUNWALD E., WAGNER H. N., Jr The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest. 1956 Dec;35(12):1412–1418. doi: 10.1172/JCI103398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Busse R., Trogisch G., Bassenge E. The role of endothelium in the control of vascular tone. Basic Res Cardiol. 1985 Sep-Oct;80(5):475–490. doi: 10.1007/BF01907912. [DOI] [PubMed] [Google Scholar]
  7. Cowley A. W., Jr, Merrill D., Osborn J., Barber B. J. Influence of vasopressin and angiotensin on baroreflexes in the dog. Circ Res. 1984 Feb;54(2):163–172. doi: 10.1161/01.res.54.2.163. [DOI] [PubMed] [Google Scholar]
  8. Cowley A. W., Jr, Monos E., Guyton A. C. Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ Res. 1974 Apr;34(4):505–514. doi: 10.1161/01.res.34.4.505. [DOI] [PubMed] [Google Scholar]
  9. Floras J. S., Aylward P. E., Abboud F. M., Mark A. L. Inhibition of muscle sympathetic nerve activity in humans by arginine vasopressin. Hypertension. 1987 Oct;10(4):409–416. doi: 10.1161/01.hyp.10.4.409. [DOI] [PubMed] [Google Scholar]
  10. Fujita T., Ito Y., Noda H., Sato Y., Ando K., Kangawa K., Matsuo H. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man. J Clin Invest. 1987 Sep;80(3):832–840. doi: 10.1172/JCI113141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furchgott R. F. Role of endothelium in responses of vascular smooth muscle. Circ Res. 1983 Nov;53(5):557–573. doi: 10.1161/01.res.53.5.557. [DOI] [PubMed] [Google Scholar]
  12. Glänzer K., Prüssing B., Düsing R., Kramer H. J. Hemodynamic and hormonal responses to 8-arginine-vasopressin in healthy man: effects of indomethacin. Klin Wochenschr. 1982 Oct 1;60(19):1234–1239. doi: 10.1007/BF01716729. [DOI] [PubMed] [Google Scholar]
  13. Guo G. B., Schmid P. G., Abboud F. M. Sites at which vasopressin facilitates baroreflex inhibition of lumbar sympathetic nerve activity. Am J Physiol. 1986 Sep;251(3 Pt 2):H644–H655. doi: 10.1152/ajpheart.1986.251.3.H644. [DOI] [PubMed] [Google Scholar]
  14. Hammer M., Skagen K. Effects of small changes of plasma vasopressin on subcutaneous and skeletal muscle blood flow in man. Acta Physiol Scand. 1986 May;127(1):67–73. doi: 10.1111/j.1748-1716.1986.tb07877.x. [DOI] [PubMed] [Google Scholar]
  15. Hasser E. M., Haywood J. R., Johnson A. K., Bishop V. S. The role of vasopressin and the sympathetic nervous system in the cardiovascular response to vagal cold block in the conscious dog. Circ Res. 1984 Oct;55(4):454–462. doi: 10.1161/01.res.55.4.454. [DOI] [PubMed] [Google Scholar]
  16. Hassid A., Williams C. Vasoconstrictor-evoked prostaglandin synthesis in cultured vascular smooth muscle. Am J Physiol. 1983 Sep;245(3):C278–C282. doi: 10.1152/ajpcell.1983.245.3.C278. [DOI] [PubMed] [Google Scholar]
  17. Holzmann S. Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips. J Cyclic Nucleotide Res. 1982;8(6):409–419. [PubMed] [Google Scholar]
  18. Honma M., Satoh T., Takezawa J., Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med. 1977 Dec;18(3):257–273. doi: 10.1016/0006-2944(77)90060-6. [DOI] [PubMed] [Google Scholar]
  19. Ignarro L. J., Harbison R. G., Wood K. S., Kadowitz P. J. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther. 1986 Jun;237(3):893–900. [PubMed] [Google Scholar]
  20. KITCHIN A. H. The effect of pitressin on hand and forearm blood flow. Clin Sci. 1957 Nov;16(4):639–644. [PubMed] [Google Scholar]
  21. Katusic Z. S., Shepherd J. T., Vanhoutte P. M. Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res. 1984 Nov;55(5):575–579. doi: 10.1161/01.res.55.5.575. [DOI] [PubMed] [Google Scholar]
  22. Kirschenbaum M. A., Lowe A. G., Trizna W., Fine L. G. Regulation of vasopressin action by prostaglandins. Evidence for prostaglandin synthesis in the rabbit cortical collecting tubule. J Clin Invest. 1982 Dec;70(6):1193–1204. doi: 10.1172/JCI110718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Liard J. F., Dériaz O., Tschopp M., Schoun J. Cardiovascular effects of vasopressin infused into the vertebral circulation of conscious dogs. Clin Sci (Lond) 1981 Sep;61(3):345–347. doi: 10.1042/cs0610345. [DOI] [PubMed] [Google Scholar]
  24. Liard J. F., Spadone J. C. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):713–719. doi: 10.1097/00005344-198407000-00026. [DOI] [PubMed] [Google Scholar]
  25. Matsuguchi H., Schmid P. G., Van Orden D., Mark A. L. Does vasopressin contribute to salt-induced hypertension in the Dahl strain? Hypertension. 1981 Mar-Apr;3(2):174–181. doi: 10.1161/01.hyp.3.2.174. [DOI] [PubMed] [Google Scholar]
  26. Montani J. P., Liard J. F., Schoun J., Möhring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res. 1980 Sep;47(3):346–355. doi: 10.1161/01.res.47.3.346. [DOI] [PubMed] [Google Scholar]
  27. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest. 1986 Jul;78(1):1–5. doi: 10.1172/JCI112536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Möhring J., Glänzer K., Maciel J. A., Jr, Düsing R., Kramer H. J., Arbogast R., Koch-Weser J. Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension. J Cardiovasc Pharmacol. 1980 Jul-Aug;2(4):367–376. doi: 10.1097/00005344-198007000-00004. [DOI] [PubMed] [Google Scholar]
  29. Nadler J., Zipser R. D., Coleman R., Horton R. Stimulation of renal prostaglandins by pressor hormones in man: comparison of prostaglandin E2 and prostacyclin (6 keto prostaglandin F1 alpha). J Clin Endocrinol Metab. 1983 Jun;56(6):1260–1265. doi: 10.1210/jcem-56-6-1260. [DOI] [PubMed] [Google Scholar]
  30. Nyhan D. P., Clougherty P. W., Murray P. A. AVP-induced pulmonary vasodilation during specific V1 receptor block in conscious dogs. Am J Physiol. 1987 Sep;253(3 Pt 2):H493–H499. doi: 10.1152/ajpheart.1987.253.3.H493. [DOI] [PubMed] [Google Scholar]
  31. Oliver J. A., Sciacca R. R., Le Cren G., Cannon P. J. Modulation by prostaglandins of the renal vascular action of arginine vasopressin. Prostaglandins. 1982 Nov;24(5):641–656. doi: 10.1016/0090-6980(82)90034-x. [DOI] [PubMed] [Google Scholar]
  32. Rane A., Oelz O., Frolich J. C., Seyberth H. W., Sweetman B. J., Watson J. T., Wilkinson G. R., Oates J. A. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther. 1978 Jun;23(6):658–668. doi: 10.1002/cpt1978236658. [DOI] [PubMed] [Google Scholar]
  33. Rapoport R. M., Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res. 1983 Mar;52(3):352–357. doi: 10.1161/01.res.52.3.352. [DOI] [PubMed] [Google Scholar]
  34. Schmid P. G., Guo G. B., Abboud F. M. Different effects of vasopressin and angiotensin II on baroreflexes. Fed Proc. 1985 May;44(8):2388–2392. [PubMed] [Google Scholar]
  35. Schwartz J., Liard J. F., Ott C., Cowley A. W., Jr Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs. Am J Physiol. 1985 Nov;249(5 Pt 2):H1001–H1008. doi: 10.1152/ajpheart.1985.249.5.H1001. [DOI] [PubMed] [Google Scholar]
  36. Seino M., Abe K., Tsunoda K., Yoshinaga K. Interaction of vasopressin and prostaglandins through calcium ion in the renal circulation. Hypertension. 1985 Jan-Feb;7(1):53–58. doi: 10.1161/01.hyp.7.1.53. [DOI] [PubMed] [Google Scholar]
  37. Takeshita A., Imaizumi T., Ashihara T., Nakamura M. Characteristics of responses to salt loading and deprivation in hypertensive subjects. Circ Res. 1982 Oct;51(4):457–464. doi: 10.1161/01.res.51.4.457. [DOI] [PubMed] [Google Scholar]
  38. Takeshita A., Imaizumi T., Nakamura N., Higashi H., Sasaki T., Nakamura M., Kangawa K., Matsuo H. Attenuation of reflex forearm vasoconstriction by alpha-human atrial natriuretic peptide in men. Circ Res. 1987 Oct;61(4):555–559. doi: 10.1161/01.res.61.4.555. [DOI] [PubMed] [Google Scholar]
  39. Undesser K. P., Hasser E. M., Haywood J. R., Johnson A. K., Bishop V. S. Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Circ Res. 1985 Mar;56(3):410–417. doi: 10.1161/01.res.56.3.410. [DOI] [PubMed] [Google Scholar]
  40. Vierhapper H., Waldhäusl W., Nowotny P. Effect of indomethacin upon angiotensin-induced changes in blood pressure and plasma aldosterone in normal man. Eur J Clin Invest. 1981 Apr;11(2 Suppl 1):85–89. doi: 10.1111/j.1365-2362.1981.tb02044.x. [DOI] [PubMed] [Google Scholar]
  41. Walker B. R. Evidence for a vasodilatory effect of vasopressin in the conscious rat. Am J Physiol. 1986 Jul;251(1 Pt 2):H34–H39. doi: 10.1152/ajpheart.1986.251.1.H34. [DOI] [PubMed] [Google Scholar]
  42. Watabe T., Tanaka K., Kumagae M., Itoh S., Kogure M., Hasegawa M., Horiuchi T., Morio K., Takeda F., Ubukata E. Role of endogenous arginine vasopressin in potentiating corticotropin-releasing hormone-stimulated corticotropin secretion in man. J Clin Endocrinol Metab. 1988 Jun;66(6):1132–1137. doi: 10.1210/jcem-66-6-1132. [DOI] [PubMed] [Google Scholar]
  43. Watabe T., Tanaka K., Kumagae M., Itoh S., Takeda F., Morio K., Hasegawa M., Horiuchi T., Miyabe S., Shimizu N. Hormonal responses to insulin-induced hypoglycemia in man. J Clin Endocrinol Metab. 1987 Dec;65(6):1187–1191. doi: 10.1210/jcem-65-6-1187. [DOI] [PubMed] [Google Scholar]
  44. Zipser R. D., Myers S. I., Needleman P. Stimulation of renal prostaglandin synthesis by the pressor activity of vasopressin. Endocrinology. 1981 Feb;108(2):495–499. doi: 10.1210/endo-108-2-495. [DOI] [PubMed] [Google Scholar]
  45. Zusman R. M., Keiser H. R. Prostaglandin biosynthesis by rabbit renomedullary interstitial cells in tissue culture. Stimulation by angiotensin II, bradykinin, and arginine vasopressin. J Clin Invest. 1977 Jul;60(1):215–223. doi: 10.1172/JCI108758. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES